AI enabled body composition analysis predicts outcomes for p

AI enabled body composition analysis predicts outcomes for patients with lung cancer treated with immunotherapy

Tafadzwa Chaunzwa, MD, a researcher in the Artificial Intelligence in Medicine (AIM) Program at Mass General Brigham and a senior resident physician at the Harvard Radiation Oncology Program, is the lead author of a paper published in JAMA Oncology.

Related Keywords

Hugo Aerts , Tafadzwal Chaunzwa , Tafadzwa Chaunzwa , Program At Mass , Harvard University , Harvard Radiation Oncology Program , Artificial Intelligence , Mass General Brigham , Body Composition ,

© 2025 Vimarsana